11:54 AM EST - Theralase Technologies Inc. : announced today that it has applied for a U.S. patent for a multi-wavelength laser light source that is capable of safely and effectively activating its patented and patent pending Photo Dynamic Compounds in the destruction of cancer at various tissue depths. Theralase Technologies Inc.
shares V.TLT are trading up $0.03 at $0.34.
